Jones Trading Starts AbCellera Biologics (ABCL) at Buy

Jones Trading analyst Debanjana Chatterjee initiates coverage on AbCellera Biologics (NASDAQ: ABCL) with a Buy rating and a price target of $11.00.

For an analyst ratings summary and ratings history on AbCellera Biologics click here. For more ratings news on AbCellera Biologics click here.

Shares of AbCellera Biologics closed at $3.43 yesterday.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• OpenAI says its agents leaked some user images - Reuters
• Northrop Grumman wins $143M in new U.S. defense contracts